Sharp Brains: Brain Fitness and Cognitive Health News

Meet these world-class experts and innovators

Confirmed Summit Speakers

Dr. Andrea Serino, Head of Neuroscience at MindMaze

Andrea Seri­no is cur­rent­ly Head of Neu­ro­science at Mind­Maze and Invit­ed Pro­fes­sor at the Cen­ter for Neu­ro­pros­thet­ics of the EPFL, and he will be SNSF Pro­fes­sor at the Uni­ver­si­ty Hos­pi­tal of Lau­sanne from 2017. He got his PhD in Neu­ropsy­chol­o­gy at the Uni­ver­si­ty of Bologna, where he was also assis­tant pro­fes­sor from 2006 to 2012. His main research top­ic is under­stand­ing the neu­rocog­ni­tive basis of body and self expe­ri­ence in space. To this aim he has used mul­ti­ple exper­i­men­tal tech­niques, both in healthy vol­un­teers and in brain dam­aged or neu­ropsy­chi­atric patients, includ­ing psy­chophysics, non-inva­sive brain stim­u­la­tion, fMRI, EEG and neur­al net­work mod­el­ling. He received in 2006 the De Ren­zi Prize from the Ital­ian soci­ety of Neu­ropsy­chol­o­gy and in 2016 the Leenards Prize for trans­la­tion­al research.

Alexandra Morehouse

Alexandra Morehouse, CMO of Banner Health

Alexan­dra M. More­house is Senior Vice Pres­i­dent & Chief Mar­ket­ing Offi­cer for Ban­ner Health, one of the nation’s largest non­prof­it health sys­tems. Pri­or to Ban­ner Health, she was the Vice Pres­i­dent of Brand Man­age­ment at Kaiser Per­ma­nente. Pre­vi­ous­ly, Ms. More­house was CMO of AAA, where she over­saw all strat­e­gy, adver­tis­ing, brand­ing, media rela­tions, and cus­tomer rela­tion­ship man­age­ment. Ms. More­house has also served as co-chair of the Har­vard Busi­ness School Glob­al Tech­nol­o­gy Con­fer­ence and on the boards of the Har­vard Busi­ness School Com­mu­ni­ty Part­ners, Snap­Fish, Yer­ba Bue­na Cen­ter for the Arts, ODC Dance, and UC Davis. She grad­u­at­ed with high hon­ors from Har­vard Uni­ver­si­ty and has an M.B.A. from Har­vard Busi­ness School.

Alison Fenney, Executive Director of the Neurotechnology Industry Organization (NIO)

Pri­or to NIO, Ali­son was Man­ag­er of Indus­try Rela­tions at the Ontario Brain Insti­tute (OBI) in Cana­da, where she devel­oped and launched sev­er­al inno­v­a­tive fund­ing pro­grams for seed stage and prod­uct devel­op­ment invest­ments. Pri­or to the OBI Ali­son worked in Equi­ty Research at Bloom Bur­ton & Co, a bou­tique life sci­ence invest­ment bank in Toron­to, Cana­da. She also served on the board of AGE Inc. a social ven­ture devel­op­ing edu­ca­tion­al tools for front­line health­care staff. Ali­son has a PhD in Neu­ro­science and an MBA from McMas­ter Uni­ver­si­ty, a Mas­ters in Neu­ro­ki­net­ics from the Uni­ver­si­ty of Que­bec at Mon­tre­al, and a Bach­e­lor of Kine­si­ol­o­gy (hon­ors) from Brock University.

Alvaro Fernandez

Alvaro Fernandez, CEO and Editor-in-Chief of SharpBrains

Alvaro Fer­nan­dez, named a Young Glob­al Leader by the World Eco­nom­ic Forum, runs Sharp­Brains, an inde­pen­dent mar­ket research firm track­ing health and per­for­mance appli­ca­tions of brain sci­ence. He has been quot­ed by The New York Times, The Wall Street Jour­nal, and CNN, among oth­ers. Mr. Fer­nan­dez is the co-author of “The Sharp­Brains Guide to Brain Fit­ness: How to Opti­mize Brain Health and Per­for­mance at Any Age” (trans­lat­ed into Span­ish, Pol­ish and Japan­ese), and the Edi­tor-in-chief of Sharp­Brains’ recent mar­ket report on Per­va­sive Neu­rotech­nol­o­gy and IP. Alvaro has an MBA and MA in Edu­ca­tion from Stan­ford Uni­ver­si­ty, and a BA in Eco­nom­ics from Uni­ver­si­dad de Deusto in his native Spain.

Robert Bilder

Dr. Bob Bilder, Direc­tor of the UCLA Ten­nen­baum Cen­ter for the Biol­ogy of Creativity

Dr. Bob Bilder is the Direc­tor of the Ten­nen­baum Cen­ter for the Biol­ogy of Cre­ativ­ity in the Jane & Ter­ry Semel Insti­tute for Neu­ro­science and Human Behav­ior, and the Michael E. Ten­nen­baum Fam­ily Pro­fes­sor of Psy­chi­a­try & Biobe­hav­ioral Sci­ences and Chief of Med­ical Psy­chol­ogy — Neu­ropsy­chol­ogy at David Gef­fen School of Med­i­cine. He has received many awards for his research con­tri­bu­tions, served on diverse fed­eral and inter­na­tional advi­sory boards, pro­vided edi­to­r­ial ser­vice to many schol­arly jour­nals, and received mul­ti­ple grants from the NIH, pri­vate foun­da­tions, and indus­try. Learn more.

Dr. Brian Iacoviello, Director of Scientific Affairs at Click Therapeutics

Bri­an com­bines clin­i­cal and sci­en­tif­ic ini­tia­tives at Click Ther­a­peu­tics with his role as Assis­tant Pro­fes­sor of Psy­chi­a­try at the Icahn School of Med­i­cine at Mount Sinai. Pri­or to join­ing Click Ther­a­peu­tics, he was the Direc­tor of Psy­chother­a­py Research in the Mood and Anx­i­ety Dis­or­ders Pro­gram at Mount Sinai, con­duct­ing over $1M in NIH and foun­da­tion-fund­ed research inves­ti­gat­ing neu­robe­hav­ioral inter­ven­tions for mood and anx­i­ety dis­or­ders. He holds a Ph.D. and M.A., Clin­i­cal Psy­chol­o­gy, from Tem­ple Uni­ver­si­ty; and a B.A. with Hon­ors in Psy­chol­o­gy and Entre­pre­neur­ship from Johns Hop­kins University.

Charlie Hartwell

Charlie Hartwell, Operating Partner at the Bridge Builders Collaborative

Char­lie helps fund and sup­port the visions of social entre­pre­neurs who have scal­able busi­ness mod­els for appli­ca­tions, prac­tices, prod­ucts and tools that build bridges for mind-train­ing. He is a Har­vard Busi­ness School grad­u­ate who has led, found­ed, run and worked in orga­ni­za­tions in 16 dif­fer­ent indus­tries. Pre­vi­ous­ly Char­lie was Pres­i­dent of Ideas to Go, an inno­va­tion-con­sult­ing firm. His career has includ­ed Wall Street, cor­po­rate mar­ket­ing stints at HJ Heinz and Pills­bury. In 1998, he formed your­ex­pe­di­tion, the first for-prof­it expe­di­tion com­pa­ny in U.S. his­to­ry, launched by the his­toric Ban­croft Arne­sen Expe­di­tion across Antarc­ti­ca by polar explor­ers Ann Ban­croft and Liv Arnesen.

Dr. Corey McCann, CEO of Pear Therapeutics

Corey has back­ground as a physi­cian, sci­en­tist, entre­pre­neur, and health­care investor. Pri­or to found­ing Pear, he was an investor with MPM Cap­i­tal and with River­Vest Ven­ture Part­ners. Pre­vi­ous­ly he was with McK­in­sey & Com­pa­ny, where he advised phar­ma­ceu­ti­cal, med­ical device, and biotech­nol­o­gy com­pa­nies and led McKinsey’s Cen­tral Ner­vous Sys­tem (CNS) exper­tise group, serv­ing clients across phar­ma and biotech. He is a found­ing mem­ber of mul­ti­ple start-ups includ­ing Alcy­one Life­sciences. Dr. McCann’s post-grad­u­ate train­ing was at Har­vard Uni­ver­si­ty, Wash­ing­ton Uni­ver­si­ty in St Louis, and at the Mass­a­chu­setts Gen­er­al Hos­pi­tal, and he grad­u­at­ed sum­ma cum laude from The Penn­syl­va­nia State Uni­ver­si­ty where he was an Evan Pugh Scholar.

Dr. Daniel Perez-Marcos, Senior Scientist at MindMaze

Dr. Daniel Perez-Mar­cos received the Dr.-Ing. degree in Bio­med­ical Engi­neer­ing in 2007 (TU Ilme­nau, Ger­many), for the devel­op­ment of neu­ro­feed­back appli­ca­tions for the treat­ment of cog­ni­tive impair­ments in epilep­sy. Daniel joined Mind­Maze in 2012. His mis­sion is to ensure sci­en­tif­ic, clin­i­cal and tech­no­log­i­cal excel­lence of the com­pa­ny’s vir­tu­al real­i­ty health­care solu­tions for neu­rore­ha­bil­i­ta­tion. Pri­or to join­ing Mind­Maze, Daniel was a sci­en­tif­ic researcher at IDIBAPS and the Exper­i­men­tal Vir­tu­al Envi­ron­ments Lab for Neu­ro­science and Tech­nol­o­gy in Barcelona from 2006 to 2012, where he worked on the inte­gra­tion of immer­sive vir­tu­al real­i­ty, body own­er­ship, brain-com­put­er inter­faces and hap­tics to enhance telep­res­ence expe­ri­ences for psy­chol­o­gy and neu­ro­science applications.

Debra Gilmore, Exec­u­tive Director of The Arrow­smith Program

Deb­bie Gilmore is the new Exec­u­tive Direc­tor of Arrow­smith Pro­gram, hav­ing been Arrowsmith’s rep­re­sen­ta­tive in Aus­tralia and New Zealand for 18 months. Deb­bie first heard about the Arrow­smith Pro­gram when she was Head of Diverse Learn­ing Needs at the Catholic Edu­ca­tion Office, Syd­ney, Aus­tralia. Her work as a teacher, lit­er­a­cy advis­er, assis­tant prin­ci­pal and prin­ci­pal helped her under­stand the need to ‘unlock’ the poten­tial of stu­dents with learn­ing dif­fi­cul­ties, and her role as a moth­er of a son with such chal­lenges gave her first hand expe­ri­ence of their strug­gles. Deb­bie holds a Mas­ters of Edu­ca­tion and var­i­ous Grad­u­ate Cer­tifi­cates in Education.

Dr. Eddie Martucci, CEO of Akili Interactive Labs

Dr. Mar­tuc­ci is co-founder and CEO at Akili Inter­ac­tive Labs, a dig­i­tal health com­pa­ny aim­ing to make the first reg­u­la­to­ry-approved diag­nos­tic and ther­a­peu­tic video games. He spear­head­ed the clin­i­cal part­ner­ships that Akili now has with Pfiz­er and mul­ti­ple top-tier aca­d­e­m­ic insti­tu­tions. Dr. Mar­tuc­ci is also a Prin­ci­pal at PureTech Ven­tures. He was pre­vi­ous­ly a Kauff­man Entre­pre­neur Fel­low. Dr. Mar­tuc­ci com­plet­ed his grad­u­ate work at Yale Uni­ver­si­ty in the Depart­ments of Phar­ma­col­o­gy and Mol­e­c­u­lar Bio­physics & Bio­chem­istry, and received a BS in Bio­chem­istry from Prov­i­dence Col­lege and a PhD and MPhil from Yale University.

Edward Kliphuis, Investment Director of Merck Ventures

Edward Kli­phuis, Invest­ment Direc­tor at Mer­ck Ven­tures and Board Observ­er at Akili Inter­ac­tive Labs, looks for new invest­ment oppor­tu­ni­ties for the 300 mil­lion euro Mer­ck Ven­tures fund. Pre­vi­ous­ly he was at Kem­pen & Co, a pan Euro­pean mer­chant bank head­quar­tered in Ams­ter­dam, the Nether­lands, where he worked in the Life Sci­ences Secu­ri­ties team. Edward was instru­men­tal in the team’s con­tin­u­ous fundrais­ing efforts for list­ed Euro­pean small and mid-cap biotech com­pa­nies in over 20 deals. He holds an M.Sc. degree in Bio­phar­ma­ceu­ti­cal Sci­ences from Lei­den Uni­ver­si­ty, the Nether­lands, with spe­cial­iza­tions in phar­ma­col­o­gy and sci­ence based business.

Elizabeth Zelinski

Dr. Elizabeth Zelinski, Director of the Digital Aging Center at USC Davis School of Gerontology

Dr. Eliz­a­beth Zelin­s­ki stud­ies mech­a­nisms of lon­gi­tu­di­nal changes in mem­o­ry, intel­li­gence, and lan­guage in healthy adults aged 30 – 97. She believes that some of the neg­a­tive change asso­ci­at­ed with aging can be reduced by engage­ment in chal­leng­ing activ­i­ties such as cog­ni­tive train­ing games. She served as a prin­ci­pal inves­ti­ga­tor of the IMPACT study, a large clin­i­cal tri­al of a pro­gram that uses prin­ci­ples of brain plas­tic­i­ty. She recent­ly found that mod­est improve­ments to healthy old­er adults’ cog­ni­tion with direct train­ing were equiv­a­lent to the improve­ments seen with aer­o­bic exer­cise inter­ven­tions. Zelin­s­ki has been pres­i­dent of the Amer­i­can Psy­cho­log­i­cal Asso­ci­a­tion Divi­sion of Adult Devel­op­ment and Aging, is the the Rita and Edward Polusky Chair in Edu­ca­tion and Aging and pro­fes­sor of geron­tol­ogy and psy­chol­o­gy in the Davis School of Geron­tol­ogy at the Uni­ver­si­ty of South­ern Cal­i­for­nia and is the inau­gur­al Direc­tor of its Dig­i­tal Aging Center.

Dr. Gahan Pandina, Senior Director & Venture Leader at Janssen Research & Development

Work­ing at Janssen Research and Devel­op­ment, Phar­ma­ceu­ti­cal Com­pa­nies of John­son & John­son, Dr. Pan­d­i­na’s team is devel­op­ing a sys­tem of tools and tech­nolo­gies to opti­mize nov­el med­ica­tion devel­op­ment for Autism Spec­trum Dis­or­der (ASD). Over the past 14 years at Janssen, Dr. Pan­d­i­na has served as the clin­i­cal leader for sev­er­al glob­al, Phase 2a/2b drug devel­op­ment pro­grams in the areas of schiz­o­phre­nia & cog­ni­tion, ADHD, mood, and sleep dis­or­ders. He is a licensed clin­i­cal psy­chol­o­gist, and serves on the board of two non-prof­it orga­ni­za­tions focused on men­tal health. He received a BA in Psy­chol­o­gy from the Uni­ver­si­ty of Ver­mont, and a PhD in Clin­i­cal Psy­chol­o­gy from Bing­ham­ton Uni­ver­si­ty in Bing­ham­ton, NY, and com­plet­ed doc­tor­al fel­low­ships in both Neu­ropsy­chol­o­gy and Child and Ado­les­cent Neu­ropsy­chol­o­gy at the Robert Wood John­son Med­ical School.

Dr. Judson Brewer, Founder & Research Lead of Claritas Mindsciences

Dr. Jud­son Brew­er MD, PhD, the founder of Clar­i­tas Mind­Sciences and cre­ator of Eat Right Now and Crav­ing to Quit, is a thought leader in habit change and the “sci­ence of self-mas­tery,” with 20 years of expe­ri­ence in mind­ful­ness train­ing. He has taught at Yale Uni­ver­si­ty, pub­lished numer­ous peer-reviewed arti­cles and book chap­ters, spo­ken at inter­na­tion­al con­fer­ences, and his work has been fea­tured at TEDMED, TEDx, Time mag­a­zine, Forbes, BBC, NPR, and oth­ers. Cur­rent­ly, on top of found­ing Clar­i­tas, Jud is also an Asso­ciate Pro­fes­sor of Psy­chi­a­try and Med­i­cine at Uni­ver­si­ty of Mass­a­chu­setts School of Med­i­cine, where he is Direc­tor of Research at the Cen­ter for Mindfulness.


Dr. Kenneth Kosik, Co-Director of the UC Santa Barbara Neuroscience Research Institute

Dr. Kosik received his M.D. degree from the Med­ical Col­lege of Penn­syl­va­nia, com­plet­ed a neu­rol­o­gy res­i­den­cy from Tufts New Eng­land Med­ical Cen­ter, and held var­i­ous appoint­ments at the Har­vard Med­ical School. In the fall of 2004 he assumed the co-direc­tor­ship of the Neu­ro­science Research Insti­tute and the Har­ri­man Chair at the Uni­ver­si­ty of Cal­i­for­nia San­ta Bar­bara. He has received mul­ti­ple awards, includ­ing a Whitak­er Health Sci­ences Award from MIT, the Derek Den­ny-Brown Neu­ro­log­i­cal Schol­ar Award from the ANA, the Zenith Award from the Alzheimer’s Asso­ci­a­tion, and a NASA Group Achieve­ment Award.

Linda Raines, CEO of the Mental Health Association of Maryland

Lin­da Raines has been work­ing at the Men­tal Health Asso­ci­a­tion of Mary­land in sev­er­al capac­i­ties for 30 years. For 100 years, the Men­tal Health Asso­ci­a­tion of Mary­land has addressed the men­tal health needs of Mary­lan­ders of all ages through pro­grams that edu­cate the pub­lic to increase under­stand­ing and pro­vide resources, advance pub­lic pol­i­cy to improve care and out­comes, and mon­i­tor the qual­i­ty of ser­vices received by indi­vid­u­als liv­ing with men­tal ill­ness and sub­stance use dis­or­ders. Pre­vi­ous­ly, Lin­da was a Polit­i­cal Orga­niz­er & Leg­isla­tive Asso­ciate at Com­mon Cause.

Dr. Margaret Grabb, SBIR/STTR Program Director at the National Institute of Mental Health (NIMH)

Dr. Grabb over­sees the Small Busi­ness Inno­va­tion Research (SBIR) and Small Busi­ness Tech­nol­o­gy Trans­fer (STTR) Pro­grams at the NIMH, with a $40M annu­al bud­get that sup­ports a diverse tech­nol­o­gy port­fo­lio rang­ing from the lat­est advance­ments in areas such as opto­ge­net­ics and large scale elec­tro­phys­i­o­log­i­cal record­ing, to drug and device devel­op­ment, high through­put screen­ing tools, bio­mark­ers and mobile health tech­nolo­gies. The goals and objec­tives for these pro­grams aim to: 1) iden­ti­fy and pro­mote spe­cif­ic com­mer­cial­iz­able tech­nol­o­gy devel­op­ment that could ben­e­fit NIMH stake­hold­ers and 2) iden­ti­fy bot­tle­necks in the com­mer­cial­iza­tion of bio­med­ical tech­nolo­gies and pro­vide solu­tions to the issues. Dr. Grabb devel­oped the first SBIR Phase II com­pet­ing renew­al solic­i­ta­tion that sup­ports tech­nol­o­gy devel­op­ment into the “the val­ley of death”. She has also played an active part in the NIH SBIR Tech­ni­cal Assis­tance Pro­grams that pro­vide SBIR grantees with com­mer­cial­iza­tion assis­tance. Addi­tion­al­ly, she man­ages a non-SBIR pro­gram that sup­ports the devel­op­ment and test­ing of nov­el ther­a­peu­tics for pedi­atric men­tal dis­or­ders. Dr. Grabb has received sev­er­al NIMH Director’s Awards for achieve­ments in pro­gram devel­op­ment, lead­er­ship and management.

Margaret Moore, Co-Founder of the Institute of Coaching at McLean Hospital

Mar­garet Moore (aka Coach Meg) is co-founder and co-direc­tor of the Insti­tute of Coach­ing at McLean Hos­pi­tal, an affil­i­ate of Har­vard Med­ical School. She is a 17-year vet­er­an of the biotech­nol­o­gy indus­try, where she served in mul­ti­ple exec­u­tive roles until 2000, when she shift­ed from high tech med­i­cine to coach­ing in health­care and well­ness, and found­ed Well­coach­es Cor­po­ra­tion — strate­gic part­ner of the Amer­i­can Col­lege of Sports Med­i­cine. She is a co-founder and exec­u­tive board mem­ber of the Nation­al Con­sor­tium for Cre­den­tial­ing Health & Well­ness Coach­es and led the for­ma­tion of a strate­gic part­ner­ship with the Nation­al Board of Med­ical Exam­in­ers to deliv­er nation­al stan­dards and cer­ti­fi­ca­tion of health and well­ness coaches.

Mark Watson, Co-Director of the Watson Centre for Brain Health

As an edu­ca­tor and ath­lete, Mark has always appre­ci­at­ed the role of reha­bil­i­ta­tion in increas­ing per­for­mance. As the co-Direc­tor of the Wat­son Cen­tre for Brain Health, Mark’s mis­sion is to improve the lives of peo­ple that have suf­fered a brain injury and/or con­cus­sion by imple­ment­ing brain chang­ing pro­grams to increase brain capac­i­ties and cog­ni­tive func­tion­ing. He’s also the CEO of Eaton Edu­ca­tion­al Group, which runs sev­er­al schools to help stu­dents with learn­ing dis­abil­i­ties. Mark holds a Bachelor’s degree in Phys­i­cal Edu­ca­tion and Recre­ation from the Uni­ver­si­ty of Alber­ta, and a Master’s degree in Edu­ca­tion­al Leadership.

Michael Meagher, Pres­i­dent of Cogniciti

Michael Meagher runs Cog­nic­i­ti, the cog­ni­tive health spin-off from research cen­ter and hos­pi­tal Bay­crest up in Ontario, Cana­da. His expe­ri­ence has been a mix of ser­i­al entre­pre­neur and cor­po­rate exec­u­tive. His career began with a 9‑year stint in Proc­ter & Gam­ble, and con­tin­ued by run­ning 5 suc­cess­ful busi­ness ser­vices firms where he helped cre­ate more than 3,000 net new jobs. Michael has been a lec­tur­er at the Ivey School of Busi­ness, co-authored a book on envi­ron­men­tal mar­ket­ing, man­aged a suc­cess­ful fed­er­al elec­tion cam­paign, chaired and served on numer­ous Boards, and received mul­ti­ple awards from the Young Pres­i­dents Organization.

Dr. Michael Merzenich, Emeritus Professor at UCSF and Winner of the 2016 Kavli Prize in Neuroscience

For more than three decades, Dr. Merzenich has been a lead­ing pio­neer in brain plas­tic­i­ty research. In the late 1980s, Dr. Merzenich was on the team that invent­ed the cochlear implant, now dis­trib­uted by Advanced Bion­ics. In 1996, Dr. Merzenich was the found­ing CEO of Sci­en­tif­ic Learn­ing Cor­po­ra­tion (Nas­daq: SCIL), and in 2004 became co-founder and Chief Sci­en­tif­ic Offi­cer of Posit Sci­ence. Dr. Merzenich earned his BS degree at the Uni­ver­si­ty of Port­land and his PhD at Johns Hop­kins. He retired from his long career as Fran­cis A. Sooy Pro­fes­sor and Co-Direc­tor of the Keck Cen­ter for Inte­gra­tive Neu­ro­science at the Uni­ver­si­ty of Cal­i­for­nia at San Fran­cis­co in 2007. He was elect­ed to the Nation­al Acad­e­my of Sci­ences, the Insti­tute of Med­i­cine, and recent­ly won the 2016 Kavli Prize in Neuroscience

Dr. Neal Cohen, clinical psychologist at The Synapse System

Dr. Cohen is a Geor­gia licensed psy­chol­o­gist with over 20 years of expe­ri­ence in the assess­ment and treat­ment of sub­stance use dis­or­ders. He received a Master’s degree in Clin­i­cal Psy­chol­o­gy from the Geor­gia School of Pro­fes­sion­al Psy­chol­o­gy and his Doc­tor­ate from Argosy Uni­ver­si­ty. Dr. Cohen has a par­tic­u­lar inter­est in sub­stance abuse and cog­ni­tive dis­or­ders. Present­ly, he is con­duct­ing research on how ado­les­cent sub­stance abuse pro­gram­ming can be mod­i­fied to accom­mo­date the deficits in exec­u­tive func­tion com­mon­ly found in this population.

Nikhil Sri­ra­man, IP Analyst at SharpBrains

Nikhil Sri­ra­man is a patent attor­ney admit­ted to prac­tice before the Unit­ed States Patent and Trade­mark Office (USPTO). Nikhil has held posi­tions at the USPTO, IP law firms and in-house at For­tune 500 com­pa­nies. He cur­rently serves as Primal’s Vice Pres­i­dent of Intel­lec­tual Prop­erty, as well as Sharp­Brains’ Intel­lec­tual Prop­erty Ana­lyst. With degrees by DePaul Uni­ver­si­ty Col­lege of Law and Uni­ver­si­ty of Michi­gan, Nikhil’s pro­fes­sion­al expe­ri­ence includes legal and engi­neer­ing work at Ford and John­son Controls.

Dr. Peter White­house, Pro­fes­sor of Neu­rol­ogy at Case West­ern Reserve University

Peter J. White­house, MD, PhD is Pro­fes­sor of Neu­rol­ogy as well as for­mer Pro­fes­sor of Cog­ni­tive Sci­ence, Psy­chi­a­try, Neu­ro­science, Psy­chol­ogy, Nurs­ing, Orga­ni­za­tional Behav­ior, Bioethics and His­tory. With col­leagues he dis­cov­ered fun­da­men­tal aspects of the cholin­er­gic pathol­ogy in Alzheimer’s and relat­ed demen­tias. He is clin­i­cally active at Uni­ver­sity Hos­pi­tals of Cleve­land in the Joseph Foley Elder Health Cen­ter at Fairhill Cen­ter, and his research inter­ests include the devel­op­ment of more effec­tive treat­ments for indi­vid­u­als with cog­ni­tive impair­ment, includ­ing drugs and non-bio­log­i­cal inter­ven­tions, eth­i­cal issues in the med­ical pro­fes­sion and inte­gra­tive health care systems


Richard Varn, Presidential Appointee at the Center for Advanced Technology and Neuroscience at Educational Testing Services (ETS)

Richard is focused on role of pre­dic­tive ana­lyt­ics to help edu­ca­tion gain proof of out­come and proof of val­ue, and to gain effi­cien­cy in edu­ca­tion­al set­tings. In addi­tion to work in build­ing a Cen­ter for Advanced Tech­nol­o­gy and Neu­ro­science, he serves on the Work Force Readi­ness busi­ness devel­op­ment team and over­sees Enter­prise Resilien­cy Man­age­ment. Pre­vi­ous­ly, Richard was the Chief Infor­ma­tion Offi­cer for the City of San Anto­nio and the State of Iowa, among oth­er responsibilities.

Dr. Rex Jakobovits, Founder of Vivalog Technologies and Experiad

Dr. Jakobovits is Pres­i­dent at Expe­ri­ad Solu­tions, a start­up that is devel­op­ing new soft­ware for behav­ioral ther­a­py and oth­er clin­i­cal appli­ca­tions. He is a Research Affil­i­ate with the Uni­ver­si­ty of Wash­ing­ton Autism Cen­ter and an Affil­i­ate Pro­fes­sor of Radi­ol­o­gy. His pri­or ven­ture, Viva­l­og Tech­nolo­gies, was sold to McKesson in 2008. He served as Vice Pres­i­dent at McKesson for 5 years before leav­ing to launch Expe­ri­ad in 2013. Dr. Jakobovits received his PhD in Com­put­er Sci­ence from the Uni­ver­si­ty of Wash­ing­ton in 1999. He is wide­ly pub­lished in com­put­er sci­ence and infor­mat­ics jour­nals, and has been award­ed sev­er­al patents. He has raised over $5M in seed cap­i­tal for his star­tups through NIH Small Busi­ness Inno­v­a­tive Research grants.

Rita Carter, science writer, broadcaster and BBC contributor

Rita Carter is a writer, broad­cast­er and lec­tur­er who spe­cialis­es in brain sci­ence. She is the author of “Map­ping the Mind” the first com­pre­hen­sive layman’s guide to neu­ropsy­chol­o­gy. Oth­er titles include “Explor­ing Con­scious­ness” , “Mul­ti­plic­i­ty – the New Sci­ence of Per­son­al­i­ty” and “The Brain Book”. Rita was a TV pre­sen­ter and pro­duced and pre­sent­ed radio and pro­grammes about med­i­cine and psy­chol­o­gy. She writes for a wide range of news­pa­pers and mag­a­zines, includ­ing BBC Focus, New Sci­en­tist, and the Dai­ly Mail, and talks and lec­tures about brain sci­ence through­out the world.

Ron Oberleitner, CEO of Behavior Imaging Solutions

Ron is a wide­ly rec­og­nized thought leader in the health IT and autism com­mu­ni­ties, hav­ing suc­cess­ful­ly brought numer­ous inno­va­tions to mar­ket, includ­ing Talk­A­utism and Autism­Cares. He is a lead­ing expert and wide­ly pub­lished researcher on the use of health infor­mat­ics and telemed­i­cine for spe­cial needs, all of this work in recent years stem­ming from a suc­cess­ful career with mar­ket-lead­ing med­ical device com­pa­nies. He is a wide­ly pub­lished expert on the use of health infor­mat­ics and telemed­i­cine for spe­cial needs, and has more than 20 years of exec­u­tive-lev­el man­age­ment expe­ri­ence lead­ing prod­uct devel­op­ment in large med­ical device com­pa­nies. He has proven track record of bring­ing help­ful tech­nolo­gies to mar­ket for improved clin­i­cal oper­a­tions and treat­ment of var­i­ous med­ical con­di­tions, autism and oth­er devel­op­men­tal disabilities.

Ron Riesenbach, Managing Director of the Canadian Centre for Aging and Brain Health Innovation (CC-ABHI)

On top of his role at CC-ABHI, Ron is the VP Inno­va­tion and Chief Tech­nol­o­gy Offi­cer of Bay­crest Health Sci­ences, where he leads a diverse team of pro­fes­sion­als devel­op­ing nov­el solu­tions to sup­port clin­i­cal care, research and edu­ca­tion into age­ing and brain health. Pri­or to join­ing Bay­crest, he was the VP of Emerg­ing Busi­ness with the Ontario Telemed­i­cine Net­work, and led the team that built OTN’s state-of-the-art tech­nol­o­gy infra­struc­ture, appli­ca­tions and ser­vice deliv­ery mod­el. Ron is a Pro­fes­sion­al Engi­neer, holds an MSc in Elec­tri­cal Engi­neer­ing from the Tech­nion Israel Insti­tute of Tech­nol­o­gy and an MBA from the Rot­man School of Man­age­ment at the Uni­ver­si­ty of Toronto.

Ruth Poliakine Baruchi, CEO of MyndYou

Ruth is the CEO and Founder of Myn­dY­ou, an inno­v­a­tive start-up devel­op­ing a data-dri­ven plat­form for the 43 mil­lion peo­ple liv­ing with Alzheimer’s world­wide and their fam­i­ly mem­bers so that they can more eas­i­ly and bet­ter man­age care. She brings over 15 years of expe­ri­ence in lead­er­ship and man­age­ment of inno­v­a­tive busi­ness & tech­nol­o­gy projects includ­ing Gen­er­al Man­age­ment of Med­ical Device start­up, while work­ing with cus­tomers, busi­ness part­ners and sup­pli­ers worldwide.

Sandra Bond Chapman

Dr. Sandra Bond Chapman, Founder and Director, Center for BrainHealth at The University of Texas at Dallas.

San­dra Bond Chap­man, Ph.D. is founder and chief direc­tor of the Cen­ter for Brain­Health, pro­fes­sor of behav­ioral and brain sci­ences, Dee Wyly Dis­tin­guished Uni­ver­si­ty Chair at The Uni­ver­si­ty of Texas at Dal­las and author of Mak­er Your Brain Smarter. As a cog­ni­tive neu­ro­sci­en­tist with more than 40 fund­ed research grants and more than 200 pub­li­ca­tions to her cred­it, Dr. Chap­man is com­mit­ted to unlock­ing human brain poten­tial across the lifes­pan. Her sci­en­tif­ic study elu­ci­dates and applies nov­el method­olo­gies to advance cre­ative and crit­i­cal think­ing, strength­en healthy brain devel­op­ment, pro­tect against brain decline, restore the brain after injury and incite inno­va­tion through­out life.

Sanjiv Rai, founder of

San­jiv Rai is a first-gen­er­a­tion Indi­an inno­va­tor and ser­i­al entre­pre­neur. He is the Founder, Chair­per­son and Chief Solver of mul­ti­ple star­tups under Bil­lion Inno­va­tors and Chair­per­son at ARE Tech­nolo­gies and his ven­ture ini­tia­tives AceWP Inno­va­tion Labs and Bil­lion­In­no­va­tors intend to pro­mote inno­va­tion in India and abroad. As a ser­i­al Entre­pre­neur or Inno­va­tor he has worked on AI based con­ver­gence and design algo­rithms, on a vari­ety of prod­ucts and solu­tions such as net­work con­ver­gence enabling D5 chip, AceWP, PlasmaPHI, innovate2learn, agni­ie devices, ChazeMe, SmartSAPS(Smart Secured Auto­mat­ed Pay­ment Solu­tions), coolATM and Rosen­bridges Future Cities/Smart Build­ings and CHANDRA project for NASA towards per­ma­nent human inhab­i­tan­cy on out­er planets.

Dr. Sarah Banks, Head of Neuropsychology at the Cleveland Clinic Lou Ruvo Center for Brain Health

Sarah J. Banks, PhD, is the head of the neu­ropsy­chol­o­gy pro­gram at the Cleve­land Clin­ic Lou Ruvo Cen­ter for Brain Health in Las Vegas, Neva­da. She is also Assis­tant Pro­fes­sor of Med­i­cine at Cleve­land Clin­ic Lern­er Col­lege of Med­i­cine of Case West­ern Reserve Uni­ver­si­ty. Her clin­i­cal prac­tice involves char­ac­ter­iz­ing patients’ cog­ni­tive pro­file, and inte­grat­ing this infor­ma­tion with med­ical and psy­cho­log­i­cal fac­tors to help with diag­no­sis and in sug­gest­ing appro­pri­ate inter­ven­tions. Dr. Banks is also active­ly involved in train­ing, super­vis­ing clin­i­cal psy­chol­o­gy practicum stu­dents from Uni­veristy of Neva­da Las Vegas. She has par­tic­u­lar inter­est in neu­roimag­ing, and uses struc­tur­al and func­tion­al MRI to inves­ti­gate cog­ni­tion and emotion.

Scott Pawson, Sr. Product Manager, New Product Lead at Pearson Clinical Assessment

Scott is a Sr. Prod­uct Man­ag­er and New Prod­uct Lead with Pearson’s Clin­i­cal Assess­ment group. He leads the Cog­ni­tive Inter­ven­tion port­fo­lio which includes the Cogmed and Reha­Com plat­forms. Pre­vi­ous­ly, Scott was the Gen­er­al Man­ag­er of the Pear­son Clin­i­cal Assess­ment busi­ness in Cana­da. Scott obtained his MA in Psy­chol­o­gy from Wil­frid Lau­ri­er Uni­ver­si­ty in Water­loo, Ontario. He resides and works in Burling­ton, Ontario, Cana­da with his wife & two sons.

Susan Hoffman, Director of the Osher Lifelong Learning Institute at UC-Berkeley

Susan ini­ti­at­ed the Osh­er Life­long Learn­ing Insti­tute at SFSU in 2002 and moved to UC Berke­ley in 2007 to re-envi­sion and build an entire­ly new Osh­er pro­gram. Before join­ing UC-Berke­ley, Susan worked for the Cal­i­for­nia State Uni­ver­si­ty cre­at­ing new inter­dis­ci­pli­nary and inter­na­tion­al pro­grams. Pre­vi­ous­ly, Hoff­man served for a decade as the exec­u­tive direc­tor of the Cal­i­for­nia Con­fed­er­a­tion of the Arts, advo­cat­ing for Cal­i­for­nia artists, art edu­ca­tors, and arts orga­ni­za­tions in Sacra­men­to and Wash­ing­ton D.C., and devel­op­ing cul­tur­al and edu­ca­tion­al poli­cies. Her fac­ul­ty appoint­ments have been in cre­ative writ­ing, the­atre, and polit­i­cal philosophy.

Tan Le, CEO of Emotiv

Tan Le is a tech­nol­o­gy entre­pre­neur, busi­ness exec­u­tive and sought-after speak­er. She is founder and CEO of Emo­tiv Life­sciences, a bioin­for­mat­ics com­pa­ny that advances under­stand­ing of the human brain and iden­ti­fies bio­mark­ers for men­tal and oth­er neu­ro­log­i­cal con­di­tions using elec­troen­cephalog­ra­phy (EEG). She is pur­su­ing the dream of per­form­ing inex­pen­sive and wide­spread brain func­tion screen­ing to catch ear­ly signs of autism, epilep­sy, learn­ing dis­abil­i­ties, ADHD, and oth­er con­di­tions. Tan has received many awards and appeared in innu­mer­able ‘Who’s Who in Aus­tralia’ lists; she was named among Fast Company’s Most Influ­en­tial Women in Tech­nol­o­gy in 2010 and Forbes‘ 50 Names You Need to Know in 2011. In 2009, she was hon­ored by the World Eco­nom­ic Forum as a Young Glob­al Leader since 2009, and in 2011, she was rec­og­nized with the Auto­Vi­sion Inno­va­tions Award and hon­ored as a Monash Uni­ver­si­ty Dis­tin­guished Alum­ni Award recipient.


To learn more, you can check out the Agen­da, and the Spon­sors. Reg­is­tra­tion is open here.